SK Chemicals Co., Ltd. - Product Pipeline Review - 2014

Published: Dec, 2014 | Pages: 52 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

SK Chemicals Co., Ltd. - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'SK Chemicals Co., Ltd. - Product Pipeline Review - 2014', provides an overview of the SK Chemicals Co., Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of SK Chemicals Co., Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of SK Chemicals Co., Ltd. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of SK Chemicals Co., Ltd.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the SK Chemicals Co., Ltd.'s pipeline products

Reasons to buy

- Evaluate SK Chemicals Co., Ltd.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of SK Chemicals Co., Ltd. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the SK Chemicals Co., Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of SK Chemicals Co., Ltd. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of SK Chemicals Co., Ltd.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of SK Chemicals Co., Ltd. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

 Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 5
SK Chemicals Co., Ltd. Snapshot 6
SK Chemicals Co., Ltd. Overview 6
Key Information 6
Key Facts 6
SK Chemicals Co., Ltd. - Research and Development Overview 7
Key Therapeutic Areas 7
SK Chemicals Co., Ltd. - Pipeline Review 10
Pipeline Products by Stage of Development 10
Pipeline Products - Monotherapy 11
Pipeline Products - Partnered Products 12
Partnered Products/Combination Treatment Modalities 13
SK Chemicals Co., Ltd. - Pipeline Products Glance 14
SK Chemicals Co., Ltd. - Late Stage Pipeline Products 14
Phase III Products/Combination Treatment Modalities 14
SK Chemicals Co., Ltd. - Clinical Stage Pipeline Products 15
Phase II Products/Combination Treatment Modalities 15
Phase I Products/Combination Treatment Modalities 16
SK Chemicals Co., Ltd. - Early Stage Pipeline Products 17
Preclinical Products/Combination Treatment Modalities 17
SK Chemicals Co., Ltd. - Unknown Stage Pipeline Products 18
Unknown Products/Combination Treatment Modalities 18
SK Chemicals Co., Ltd. - Drug Profiles 19
coagulation factor VIII (recombinant) 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
hepabulin 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
NBP-606 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
NBP-607 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
SKPCB-70M 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
SOTB-07 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
SKI-3246 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
NBP-603 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
NCE-403 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
SKI-2670 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
varicella zoster vaccine 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
conjugate vaccine 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
NBP-604 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
NBP-611 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
NCE-401 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
NCE-402 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
NCE-405 35
Product Description 35
Mechanism of Action 35
R&D Progress 35
SID-111 36
Product Description 36
Mechanism of Action 36
R&D Progress 36
SID-910 37
Product Description 37
Mechanism of Action 37
R&D Progress 37
SID-920 38
Product Description 38
Mechanism of Action 38
R&D Progress 38
Vaccine for Undisclosed Indication 39
Product Description 39
Mechanism of Action 39
R&D Progress 39
pneumococcal pneumonia vaccine 40
Product Description 40
Mechanism of Action 40
R&D Progress 40
SK Chemicals Co., Ltd. - Pipeline Analysis 41
SK Chemicals Co., Ltd. - Pipeline Products by Target 41
SK Chemicals Co., Ltd. - Pipeline Products by Route of Administration 42
SK Chemicals Co., Ltd. - Pipeline Products by Molecule Type 43
SK Chemicals Co., Ltd. - Pipeline Products by Mechanism of Action 44
SK Chemicals Co., Ltd. - Recent Pipeline Updates 45
SK Chemicals Co., Ltd. - Dormant Projects 47
SK Chemicals Co., Ltd. - Locations And Subsidiaries 48
Head Office 48
Other Locations & Subsidiaries 48
Appendix 51
Methodology 51
Coverage 51
Secondary Research 51
Primary Research 51
Expert Panel Validation 51
Contact Us 52
Disclaimer 52

List of Tables
SK Chemicals Co., Ltd., Key Information 6
SK Chemicals Co., Ltd., Key Facts 6
SK Chemicals Co., Ltd. - Pipeline by Indication, 2014 9
SK Chemicals Co., Ltd. - Pipeline by Stage of Development, 2014 10
SK Chemicals Co., Ltd. - Monotherapy Products in Pipeline, 2014 11
SK Chemicals Co., Ltd. - Partnered Products in Pipeline, 2014 12
SK Chemicals Co., Ltd. - Partnered Products/ Combination Treatment Modalities, 2014 13
SK Chemicals Co., Ltd. - Phase III, 2014 14
SK Chemicals Co., Ltd. - Phase II, 2014 15
SK Chemicals Co., Ltd. - Phase I, 2014 16
SK Chemicals Co., Ltd. - Preclinical, 2014 17
SK Chemicals Co., Ltd. - Unknown, 2014 18
SK Chemicals Co., Ltd. - Pipeline by Target, 2014 41
SK Chemicals Co., Ltd. - Pipeline by Route of Administration, 2014 42
SK Chemicals Co., Ltd. - Pipeline by Molecule Type, 2014 43
SK Chemicals Co., Ltd. - Pipeline Products by Mechanism of Action, 2014 44
SK Chemicals Co., Ltd. - Recent Pipeline Updates, 2014 45
SK Chemicals Co., Ltd. - Dormant Developmental Projects,2014 47
SK Chemicals Co., Ltd., Other Locations 48
SK Chemicals Co., Ltd., Subsidiaries 49